Clinical trial · Interventional
Phase III: Assess Conventional RT w/ Conventional Plus Accelerated Boost RT in the Treatment of Nasopharyngeal CA
A Phase III Study to Assess Conventional RT w/ Conventional Plus Accelerated Boost RT in the Treatment of Nasopharyngeal CA
NCT00535795CI-TRIAL-00037391completedPhase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Phase III: Assess conventional RT w/ conventional Plus accelerated boost RT in the treatment of nasopharyngeal CA
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Nasopharyngeal Carcinoma | Nasopharyngeal Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Radiation Therapy | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- 1
- description
- Conventional Radiation Therapy (XRT), one fraction per day, from Sunday to Thursday every week.
- interventionNames
- Radiation: Radiation Therapy
- type
- EXPERIMENTAL
- label
- 2
- description
- Conventional Plus accelerated boost Radiation Therapy (XRT), from Sunday to Thursday every week.
- interventionNames
- Radiation: Radiation Therapy
Primary outcomes (1)
- measure
- safety and efficacy
- timeFrame
- 5 years
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Patients with nasopharyngeal Carcinoma Exclusion Criteria: * Patients with carcinoma other than histo-pathologically confirmed nasopharyngeal CA
References
Publications (0)
Data not yet available
No reference posted for this study.